Cyclophosphamide in Dogs & Cats
Generic: Cyclophosphamide
Cyclophosphamide is a potent nitrogen mustard alkylating agent primarily used in veterinary oncology to treat various cancers by interfering with cellular DNA replication.
This medication is intended for dogs and cats.
Overview
Cyclophosphamide is a systemic chemotherapy agent classified as an alkylating agent, which functions by cross-linking DNA strands to inhibit cellular division. It is a cornerstone of veterinary oncology, frequently utilized in multi-drug protocols for lymphoma, leukemias, and solid tumors in both dogs and cats. Because it is a prodrug, it must be metabolized by the liver to its active form, 4-hydroxycyclophosphamide, before exerting its cytotoxic effects on rapidly dividing cells. Clinicians often pair this medication with other agents like Vincristine or Doxorubicin to achieve synergistic therapeutic responses. Unlike Lomustine (CCNU), which is highly lipid-soluble and penetrates the blood-brain barrier effectively, cyclophosphamide has different distribution characteristics that make it ideal for systemic malignancies including mast cell tumors and carcinomas. When protocols require broader coverage, it is occasionally integrated into regimens alongside Vinblastine or Procarbazine, depending on the specific staging and biological behavior of the neoplasm. It is imperative that owners understand the complexity of these protocols, as improper administration or dosage errors can lead to significant toxicity. Veterinarians must perform serial complete blood counts (CBC) to monitor for myelosuppression, a predictable and dose-limiting side effect of cyclophosphamide treatment. The integration of supportive care is also essential when managing patients receiving this drug, as specific complications like sterile hemorrhagic cystitis require prompt medical intervention.
What It Treats
- Multicentric lymphoma: Often used in combination chemotherapy protocols (e.g., CHOP).
- Solid tumors: Used for various carcinomas and sarcomas.
- Leukemias: Helps control the proliferation of abnormal hematopoietic cells.
- Immune-mediated diseases: Occasionally used as a steroid-sparing agent in refractory autoimmune conditions.
How It Works
Cyclophosphamide acts as an alkylating agent that adds an alkyl group to the guanine base of DNA. This process results in the cross-linking of DNA strands, which effectively prevents the DNA double helix from unwinding and replicating. Since cancer cells rely on rapid division for survival, this damage triggers cell cycle arrest and apoptosis (programmed cell death). Because the drug affects any rapidly dividing cell, it also impacts healthy tissues such as bone marrow and the lining of the gastrointestinal tract, leading to many of the observed side effects. The liver plays a crucial role in activation, converting the stable parent compound into active metabolites that travel through the bloodstream to reach tumor sites throughout the body.
Dosage
Dosage is highly individualized based on the patient's body surface area (BSA), disease type, and prior response to treatment. You must strictly follow the dosing schedule provided by your veterinary oncologist, as variations in concentration can significantly alter the risk of toxicity.
Administration
Cyclophosphamide is typically administered orally as tablets or via intravenous injection. For oral administration, tablets should generally not be split or crushed to avoid exposure to the person handling the medication, as it is a cytotoxic agent. Ensure the animal has access to fresh water at all times to promote frequent urination, which helps reduce the concentration of active metabolites in the bladder and minimizes the risk of sterile hemorrhagic cystitis.
Storage
Store cyclophosphamide in its original, child-proof, and light-resistant packaging at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). Keep the medication out of reach of children and other pets, and handle with gloves if possible to prevent skin absorption of the active compound.
Contraindications
Cyclophosphamide is contraindicated in patients with known hypersensitivity to the drug or those currently suffering from significant pre-existing bone marrow suppression or severe infections. It should be used with extreme caution in animals with impaired renal or hepatic function, as these organs are vital for the metabolism and excretion of the drug and its metabolites. Because it is a potent immunosuppressant, it should generally be avoided in patients with active, untreated systemic infections. Furthermore, due to its teratogenic potential, it is strictly contraindicated for use in pregnant or lactating animals, as the drug crosses the placenta and is excreted in milk, posing severe risks to developing fetuses or nursing offspring.
Interactions
Known drug interactions include phenobarbital, which may induce hepatic enzymes and alter the metabolic activation of cyclophosphamide. Other chemotherapy agents, such as [Methotrexate](/medications/methotrexate-in-dogs-and-cats), may enhance the myelosuppressive effects, requiring careful dose adjustment and monitoring. Combining cyclophosphamide with cardiotoxic drugs or those that affect the bladder lining requires close clinical observation to prevent compounding toxicities. Always inform your veterinarian of all supplements and concurrent medications to avoid dangerous pharmacodynamic interference.
Side Effects
- Myelosuppression (low white blood cell counts)
- Sterile hemorrhagic cystitis (bladder inflammation/bleeding)
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Alopecia (hair loss, particularly in breeds with continuously growing hair)
- Hepatotoxicity (liver enzyme elevation)
- Infertility or reproductive toxicity
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
